Transmissibility of systemic amyloidosis by a prion-like mechanism.
The generation of amyloid fibrils from an amyloidogenic polypeptide occurs by a nucleation-dependent process initiated in vitro by seeding the protein solution with preformed fibrils. This phenomenon is evidenced in vivo by the fact that amyloid protein A (AA) amyloidosis in mice is markedly accelerated when the animals are given, in addition to an inflammatory stimulus, an i.v. injection of protein extracted from AA amyloid-laden mouse tissue. Heretofore, the chemical nature of this "amyloid enhancing factor" (AEF) has not been definitively identified. Here we report that the active principle of AEF extracted from the spleen of mice with silver nitrate-induced AA amyloidosis was identified unequivocally as the AA fibril itself. Further, we demonstrated that this material was extremely potent, being active in doses <1 ng, and that it retained its biologic activity over a considerable length of time. Notably, the AEF was also effective when administered orally. Our studies have provided evidence that AA and perhaps other forms of amyloidosis are transmissible diseases, akin to the prion-associated disorders.
Lundmark
Katarzyna
K
Division of Molecular and Immunological Pathology, Linköping University, 581 83 Linköping, Sweden.
Westermark
Gunilla T
GT
Nyström
Sofia
S
Murphy
Charles L
CL
Solomon
Alan
A
Westermark
Per
P
D000284:Administration, Oral; D000686:Amyloidosis / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D005260:Female; D006023:Glycoproteins / Q000008:administration & dosage / Q000378:metabolism*; D051379:Mice; D011328:Prions; D013997:Time Factors
D006023:Glycoproteins; D011328:Prions; C046748:amyloid enhancing factor